1. Home
  2. RGP vs KRRO Comparison

RGP vs KRRO Comparison

Compare RGP & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Resources Connection Inc.

RGP

Resources Connection Inc.

HOLD

Current Price

$4.41

Market Cap

138.0M

ML Signal

HOLD

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$11.48

Market Cap

150.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGP
KRRO
Founded
1996
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
138.0M
150.0M
IPO Year
2000
2019

Fundamental Metrics

Financial Performance
Metric
RGP
KRRO
Price
$4.41
$11.48
Analyst Decision
Strong Buy
Buy
Analyst Count
1
12
Target Price
$7.00
$34.80
AVG Volume (30 Days)
251.5K
76.2K
Earning Date
04-08-2026
05-13-2026
Dividend Yield
6.85%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$551,331,000.00
$6,392,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
181.46
52 Week Low
$3.06
$5.20
52 Week High
$6.07
$55.89

Technical Indicators

Market Signals
Indicator
RGP
KRRO
Relative Strength Index (RSI) 65.19 39.82
Support Level $4.22 $10.81
Resistance Level $4.86 $14.52
Average True Range (ATR) 0.18 0.85
MACD 0.03 -0.23
Stochastic Oscillator 83.97 2.57

Price Performance

Historical Comparison
RGP
KRRO

About RGP Resources Connection Inc.

Resources Connection Inc provides consulting and business initiative support services predominantly through its operative subsidiary, Resources Global Professionals. It has two segments RGP ( Resources Global Professionals.) and Sitrick. The RGP segment is focused on delivering consulting services catering to its client's operational needs and change initiatives utilizing a combination of bench and on-demand, talent. The Sitrick segment provides corporate, financial, transactional, and crisis communication and management services. The company generates a majority of its revenue from the RGP segment. Geographically, it derives its key revenue from North America and the rest from Europe and the Asia Pacific region.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Share on Social Networks: